BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 26216644)

  • 1. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
    Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
    J Urol; 2016 May; 195(5):1529-1538. PubMed ID: 26614889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Babar M; Loloi J; Tang K; Singh S; Ines M; Patel RD; Iqbal N; Ciatto M
    Prostate; 2023 May; 83(7):713-721. PubMed ID: 36879380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
    Nguyen DD; Li T; Ferreira R; Baker Berjaoui M; Nguyen AV; Chughtai B; Zorn KC; Bhojani N; Elterman D
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):22-28. PubMed ID: 37081044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.
    Gilling P; Reuther R; Kahokehr A; Fraundorfer M
    BJU Int; 2016 Jun; 117(6):923-9. PubMed ID: 26477826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes.
    Elterman D; Shepherd S; Saadat SH; Alshak MN; Bhojani N; Zorn KC; Rijo E; Misrai V; Lajkosz K; Chughtai B
    Can J Urol; 2021 Oct; 28(5):10824-10833. PubMed ID: 34657655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Is New with Rezūm Water Vapor Thermal Therapy for LUTS/BPH?
    Doppalapudi SK; Gupta N
    Curr Urol Rep; 2021 Jan; 22(1):4. PubMed ID: 33403529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.
    Capitán C; Blázquez C; Martin MD; Hernández V; de la Peña E; Llorente C
    Eur Urol; 2011 Oct; 60(4):734-9. PubMed ID: 21658839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
    Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
    J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Bozkurt A; Karabakan M; Keskin E; Hirik E; Balci MB; Nuhoglu B
    Urol Int; 2016; 96(2):202-6. PubMed ID: 26613256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world evidence with The Rezūm System: A retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes.
    Ines M; Babar M; Singh S; Iqbal N; Ciatto M
    Prostate; 2021 Sep; 81(13):956-970. PubMed ID: 34254333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-man Safety and Efficacy of the ClearRing Implant for the Treatment of Benign Prostatic Hyperplasia.
    Vjaters E; Nitsan D; Mullerad M; Engelstein D; Leibovitch I; Feld Y
    Eur Urol Focus; 2020 Jan; 6(1):131-136. PubMed ID: 30293945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.